Disbrow Jarrett

Disbrow Jarrett is listed in filings as Chief Business Officer at Aytu BioPharma, Inc.. This profile follows SEC Form 4 activity through Oct 7, 2025, including purchase activity. Recent filings connect the profile to Aytu BioPharma, Inc. (AYTU). The current snapshot covers public activity from Nov 8, 2024 to Oct 7, 2025. Reported amounts are shown as $25.0K to $12.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.